Información del producto
BCI-121 is an investigational drug that inhibits the enzyme lysine methyltransferase (KMT), which is involved in the methylation of histones and other cellular proteins. BCI-121 has been shown to inhibit tumor growth and induce tumor cell death by inhibiting mitochondrial functions. The mechanism of action for BCI-121 involves epigenetic regulation of gene expression, meaning that it controls the activity of genes without altering their DNA sequence. In cancer cells, BCI-121 inhibits the synthesis of DNA, RNA, and protein, leading to apoptosis. This drug also shows potential for treating inflammatory diseases such as rheumatoid arthritis by inhibiting KMT activity in immune cells.
Propiedades químicas
Consulta técnica sobre: 3D-HSA52982 BCI-121
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
